Silo Pharma’s lead program, SPC-15, is an intranasal prophylactic treatment targeting PTSD, designed to leverage rapid nose-to-brain delivery for enhanced therapeutic effect and patient compliance.
Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products ...
TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime, is the first new FDA-approved treatment for fibromyalgia ...
Alma reports on perimenopause symptoms for women over 35, emphasizing fluctuating hormones, mood changes, and the need for ...
Researchers at UCL are urging doctors 'be cautious when prescribing' gabapentinoids amid the risk of people suffering from ...
Morning Overview on MSN
Chronic pain is real—brain pathways can amplify and sustain it
Millions of people who live with chronic pain hear some version of the same dismissal: the scan looks fine, so the problem ...
Chip Chick on MSN
She got her foot chopped off after being accused of faking her pain and experiencing mysterious swelling
When TikToker Olivia Sandlin (@oneleggedliv) was five or six years old, her big toe would mysteriously swell up. Her mom would take her to the pediatrician, and eventually, the swelling would go away.
The article outlines how functional limitations, medical documentation, and residual functional capacity support SSDI claims for invisible conditions. How do invisible conditions qualify for SSDI ...
New federal standards require one month of work, but states like Indiana and Idaho are pushing for three-month requirements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results